Gene expression profile in human leukocytes.

Abstract:

:Leukocytes are classified as myelocytic or lymphocytic, and each class of leukocytes consists of several types of cells that have different phenotypes and different roles. To define the gene expression in these cells, we have performed serial analysis of gene expression (SAGE) using human leukocytes and have provided the gene database for these cells not only at the resting stage but also at the activated stage. A total of 709,990 tags from 17 libraries were analyzed for the manifestation of gene expression profiles in various types of human leukocytes. Types of leukocytes analyzed were as follows: peripheral blood monocytes, colony-stimulating factor-induced macrophages, monocyte-derived immature dendritic cells, mature/activated dendritic cells, granulocytes, natural killer (NK) cells, resting B cells, activated B cells, naive T cells, CCR4(-) memory T cells (resting T(H)1 cells), CCR4(+) memory T cells (resting T(H)2 cells), activated T(H)1 cells, and activated T(H)2 cells. Among 38,961 distinct tags that appeared more than once in the combined total libraries, 27,323 tags were found to represent unique genes in certain type(s) of leukocytes. Using probability (P) and hierarchical clustering analysis, we identified the genes selectively expressed in each type of leukocytes. Identification of the genes specifically expressed in different types of leukocytes provides not only a novel molecular signature to define different subsets of resting and activated cells but also contributes to further understanding of the biologic function of leukocytes in the host defense system.

journal_name

Blood

journal_title

Blood

authors

Hashimoto S,Nagai S,Sese J,Suzuki T,Obata A,Sato T,Toyoda N,Dong HY,Kurachi M,Nagahata T,Shizuno K,Morishita S,Matsushima K

doi

10.1182/blood-2002-06-1866

subject

Has Abstract

pub_date

2003-05-01 00:00:00

pages

3509-13

issue

9

eissn

0006-4971

issn

1528-0020

pii

2002-06-1866

journal_volume

101

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.

    abstract::To define the efficacy of venetoclax with extended follow-up and identify clinical or biological treatment effect modifiers, updated data for previously treated patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) enrolled in 4 early-phase trials were pooled. Rates of response, complete...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2018882555

    authors: Roberts AW,Ma S,Kipps TJ,Coutre SE,Davids MS,Eichhorst B,Hallek M,Byrd JC,Humphrey K,Zhou L,Chyla B,Nielsen J,Potluri J,Kim SY,Verdugo M,Stilgenbauer S,Wierda WG,Seymour JF

    更新日期:2019-07-11 00:00:00

  • Epithelial cytoprotection sustains ectopic expression of tissue-restricted antigens in the thymus during murine acute GVHD.

    abstract::Development of acute graft-versus-host disease (aGVHD) predisposes to chronic GVHD with autoimmune manifestations. A characteristic of experimental aGVHD is the de novo generation of autoreactive T cells. Central tolerance is dependent on the intrathymic expression of tissue-restricted peripheral self-antigens (TRA), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-474759

    authors: Dertschnig S,Nusspaumer G,Ivanek R,Hauri-Hohl MM,Holländer GA,Krenger W

    更新日期:2013-08-01 00:00:00

  • Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.

    abstract::A new human leukemia cell line, KT-1, was established from a patient in the blastic crisis phase of chronic myelogenous leukemia (CML). This cell line had a positive reaction for intracytoplasmic myeloperoxidase and two Philadelphia chromosomes (Ph1) [t(9;22)(q34;q11)] and lacked normal copies of chromosomes 9 and 22....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yanagisawa K,Yamauchi H,Kaneko M,Kohno H,Hasegawa H,Fujita S

    更新日期:1998-01-15 00:00:00

  • Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets.

    abstract::Hematopoietic fate maps in the developing mouse embryo remain imprecise. Definitive, adult-type hematopoiesis first appears in the fetal liver, then progresses to the spleen and bone marrow. Clonogenic common lymphoid progenitors and clonogenic common myeloid progenitors (CMPs) in adult mouse bone marrow that give ris...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.627

    authors: Traver D,Miyamoto T,Christensen J,Iwasaki-Arai J,Akashi K,Weissman IL

    更新日期:2001-08-01 00:00:00

  • Unmaintained remissions in multiple myeloma.

    abstract::Twenty-eight patients with multiple myeloma responding to prior melphalan-prednisone combinations, but without additional chemotherapy, were followed until relapse. Patients receiving no further treatment had a median survival time similar to that of those receiving indefinite courses of melphalan-prednisone or carmus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alexanian R,Gehan E,Haut A,Saiki J,Weick J

    更新日期:1978-06-01 00:00:00

  • Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.

    abstract::We evaluated the potential role of photoradiation therapy with a benzoporphyrin derivative, monoacid ring A (BPD-MA), and dihematoporphyrin ether (DHE), for the ex vivo purging of residual tumor cells from autologous bone marrow (BM) grafts. BPD-MA and DHE photosensitizing activity was tested against two human large-c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lemoli RM,Igarashi T,Knizewski M,Acaba L,Richter A,Jain A,Mitchell D,Levy J,Gulati SC

    更新日期:1993-02-01 00:00:00

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic regimen, but accelerated platelet generation may reduce the duration of platelet cyclooxygenase-1 (COX-1) inhibition. We performed a multicenter doubl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004596

    authors: Rocca B,Tosetto A,Betti S,Soldati D,Petrucci G,Rossi E,Timillero A,Cavalca V,Porro B,Iurlo A,Cattaneo D,Bucelli C,Dragani A,Di Ianni M,Ranalli P,Palandri F,Vianelli N,Beggiato E,Lanzarone G,Ruggeri M,Carli G,Ell

    更新日期:2020-07-09 00:00:00

  • The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population.

    abstract::The ontogeny of a 57-Kd cationic antimicrobial protein (CAP57) that has substantial similarities to bactericidal permeability increasing protein (BPI) has been determined immunocytochemically. CAP57 was detected in the granules of mature peripheral blood neutrophils. However, it was absent from other cells of the peri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pereira HA,Spitznagel JK,Winton EF,Shafer WM,Martin LE,Guzman GS,Pohl J,Scott RW,Marra MN,Kinkade JM Jr

    更新日期:1990-08-15 00:00:00

  • Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

    abstract::Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we analyzed their homing properties as well as antitumor and antivascular effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239632

    authors: Lavazza C,Carlo-Stella C,Giacomini A,Cleris L,Righi M,Sia D,Di Nicola M,Magni M,Longoni P,Milanesi M,Francolini M,Gloghini A,Carbone A,Formelli F,Gianni AM

    更新日期:2010-03-18 00:00:00

  • Metnase mediates chromosome decatenation in acute leukemia cells.

    abstract::After DNA replication, sister chromatids must be untangled, or decatenated, before mitosis so that chromatids do not tear during anaphase. Topoisomerase IIalpha (Topo IIalpha) is the major decatenating enzyme. Topo IIalpha inhibitors prevent decatenation, causing cells to arrest during mitosis. Here we report that acu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-175760

    authors: Wray J,Williamson EA,Sheema S,Lee SH,Libby E,Willman CL,Nickoloff JA,Hromas R

    更新日期:2009-08-27 00:00:00

  • Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.

    abstract::Enteropathy-associated T-cell lymphoma (EATL) is a rare subtype of peripheral T-cell lymphomas with a poor prognosis. Autologous stem cell transplantation (ASCT) was retrospectively evaluated as a consolidation or salvage strategy for EATL. The analysis included 44 patients who received ASCT for EATL between 2000 and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-11-466839

    authors: Jantunen E,Boumendil A,Finel H,Luan JJ,Johnson P,Rambaldi A,Haynes A,Duchosal MA,Bethge W,Biron P,Carlson K,Craddock C,Rudin C,Finke J,Salles G,Kroschinsky F,Sureda A,Dreger P,Lymphoma Working Party of the EBMT.

    更新日期:2013-03-28 00:00:00

  • The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

    abstract::Gene transfer in human hematopoietic stem cells (HSCs) has great potential for both gene therapy and the understanding of hematopoiesis. As HSCs have extensive proliferative capacities, stable gene transfer should include genomic integration of the transgene. Lentiviral vectors are now preferred to oncoretroviral vect...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sirven A,Pflumio F,Zennou V,Titeux M,Vainchenker W,Coulombel L,Dubart-Kupperschmitt A,Charneau P

    更新日期:2000-12-15 00:00:00

  • Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.

    abstract::All-trans retinoic acid (tRA) and arsenic trioxide (As(2)O(3)) induce non-cross-resistant complete clinical remission in patients with acute promyelocytic leukemia with t(15;17) translocation and target PML-RARalpha, the leukemogenic protein, by different pathways suggesting a possible therapeutic synergism. To evalua...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.1.264

    authors: Jing Y,Wang L,Xia L,Chen GQ,Chen Z,Miller WH,Waxman S

    更新日期:2001-01-01 00:00:00

  • Neutral tumor evolution in myeloma is associated with poor prognosis.

    abstract::Recent studies suggest that the evolutionary history of a cancer is important in forecasting clinical outlook. To gain insight into the clonal dynamics of multiple myeloma (MM) and its possible influence on patient outcomes, we analyzed whole exome sequencing tumor data for 333 patients from Myeloma XI, a UK phase 3 t...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-11-750612

    authors: Johnson DC,Lenive O,Mitchell J,Jackson G,Owen R,Drayson M,Cook G,Jones JR,Pawlyn C,Davies FE,Walker BA,Wardell C,Gregory WM,Cairns D,Morgan GJ,Houlston RS,Kaiser MF

    更新日期:2017-10-05 00:00:00

  • Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay.

    abstract::A Y-chromosome-specific in situ hybridization assay was used to assess the frequency with which host bone marrow cells are retained after marrow grafting. The majority of patients (74%) showed the presence of both host and donor marrow cells when assayed 14 days after transplant. By 84 days posttransplant only 4% of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Durnam DM,Anders KR,Fisher L,O'Quigley J,Bryant EM,Thomas ED

    更新日期:1989-11-01 00:00:00

  • CD30: seeing is not always believing.

    abstract::Although most investigators are well aware of the incredible success of brentuximab vedotin in the treatment of patients with Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL), the study by Jacobsen and colleagues in this issue of Blood demonstrates surprising activity of this agent in patients with B-ce...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-01-622480

    authors: Blum KA

    更新日期:2015-02-26 00:00:00

  • Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

    abstract::Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging diagnosis after hematopoietic stem cell transplantation. Although endothelial injury represents the final common pathway of disease, the exact pathophysiology of TA-TMA remains unclear. Potential causes include infections, chemotherapy, ra...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-02-321315

    authors: Laskin BL,Goebel J,Davies SM,Jodele S

    更新日期:2011-08-11 00:00:00

  • The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

    abstract::Staining with CD14 and CD16 monoclonal antibodies will identify two monocyte subpopulations in human blood: a major population of regular monocytes, which strongly expresses the CD14 antigen (CD14++), and a minor population with weak expression of CD14 and expression of the CD16 antigen (CD14+/CD16+ cells). As shown h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fingerle G,Pforte A,Passlick B,Blumenstein M,Ströbel M,Ziegler-Heitbrock HW

    更新日期:1993-11-15 00:00:00

  • Role of CD28 in fatal autoimmune disorder in scurfy mice.

    abstract::Scurfy mice develop CD4 T-cell-mediated lymphoproliferative disease leading to death within 4 weeks of age. The scurfy mutation causes loss of function of the foxp3 gene (foxp3(sf)), which is essential for development and maintenance of naturally occurring regulatory CD4 T cells (nTregs). In humans, mutations of the f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-054585

    authors: Singh N,Chandler PR,Seki Y,Baban B,Takezaki M,Kahler DJ,Munn DH,Larsen CP,Mellor AL,Iwashima M

    更新日期:2007-08-15 00:00:00

  • Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.

    abstract::Chronic myelogenous leukemia (CML) is characterized by the continuous proliferation and abnormal circulation of malignant hematopoietic progenitors. This may be related to the unresponsiveness of CML progenitors to beta1 integrin adhesion receptor-mediated inhibition of progenitor proliferation by the marrow microenvi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bhatia R,Verfaillie CM

    更新日期:1998-05-01 00:00:00

  • Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.

    abstract::Recently (J Pharmacol Exp Ther 261:580, 1992), we have shown that K562 leukemia cells express a calcium-signaling purinoceptor with characteristics of the P2T receptor subtype for adenosine diphosphate (ADP) previously found only in platelets. Because these results suggested that the P2T receptor may be an early marke...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murgo AJ,Contrera JG,Sistare FD

    更新日期:1994-03-01 00:00:00

  • The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy.

    abstract::Severe congenital neutropenia as well as primary myelofibrosis are rare in infancy. Elucidation of the underlying mechanism is important because it extends our understanding of the more common adult forms of these disorders. Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475566

    authors: Stepensky P,Saada A,Cowan M,Tabib A,Fischer U,Berkun Y,Saleh H,Simanovsky N,Kogot-Levin A,Weintraub M,Ganaiem H,Shaag A,Zenvirt S,Borkhardt A,Elpeleg O,Bryant NJ,Mevorach D

    更新日期:2013-06-20 00:00:00

  • Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

    abstract::In the present study, we investigated disease characteristics and clinical outcome in young patients (< 40 years) with World Health Organization (WHO)-defined essential thrombocythemia (ET) compared with early/prefibrotic primary myelofibrosis (PMF) with presenting thrombocythemia. We recruited 213 young patients (med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-407981

    authors: Barbui T,Thiele J,Carobbio A,Passamonti F,Rumi E,Randi ML,Bertozzi I,Vannucchi AM,Gisslinger H,Gisslinger B,Finazzi G,Ruggeri M,Rodeghiero F,Rambaldi A,Gangat N,Tefferi A

    更新日期:2012-07-19 00:00:00

  • The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

    abstract::Mutations of the NPM1 gene (NPM1mut) are among the most common genetic alterations in acute myeloid leukemia and are suitable for minimal residual disease detection. We retrospectively investigated the prognostic impact of NPM1mut-based minimal residual disease detection from bone marrow for development of relapse by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-10-461749

    authors: Shayegi N,Kramer M,Bornhäuser M,Schaich M,Schetelig J,Platzbecker U,Röllig C,Heiderich C,Landt O,Ehninger G,Thiede C,Study Alliance Leukemia (SAL).

    更新日期:2013-07-04 00:00:00

  • Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

    abstract::To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty p...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-11-393801

    authors: Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

    更新日期:2012-06-28 00:00:00

  • A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients.

    abstract::Annexin V has phospholipid-binding capacity and plays a potent antithrombotic role. Recently, a C to T transition has been described in the Kozak region of this gene, affecting the nucleotide preceding the initiation ATG codon. We have developed a simple method to detect this genetic change, showing by analysis of 580...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: González-Conejero R,Corral J,Roldán V,Martínez C,Marín F,Rivera J,Iniesta JA,Lozano ML,Marco P,Vicente V

    更新日期:2002-09-15 00:00:00

  • Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000).

    abstract::The reported outcome of hematopoietic stem cell transplantation (HSCT) from HLA-mismatched family members has been inconsistent. The object of this study was to evaluate the true impact of HLA-mismatch by using recent data from a homogenous population, excluding HSCT procedures that used graft manipulations, and by co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0430

    authors: Kanda Y,Chiba S,Hirai H,Sakamaki H,Iseki T,Kodera Y,Karasuno T,Okamoto S,Hirabayashi N,Iwato K,Maruta A,Fujimori Y,Furukawa T,Mineishi S,Matsuo K,Hamajima N,Imamura M

    更新日期:2003-08-15 00:00:00

  • Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.

    abstract::Programmed cell death or apoptosis is a prominent feature of low-risk myelodysplastic syndromes (MDS), although the underlying mechanism remains controversial. High-risk MDS have less apoptosis associated with increased expression of the prosurvival BCL2-related proteins. To address the mechanism and pathogenic role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-430736

    authors: Slape CI,Saw J,Jowett JB,Aplan PD,Strasser A,Jane SM,Curtis DJ

    更新日期:2012-09-20 00:00:00

  • Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

    abstract::Concurrent activation of the T-cell receptor (TCR) and complement regulator CD46 on human CD4+ T lymphocytes induces Tr1-like regulatory T cells that suppress through IL-10 secretion bystander T-cell proliferation. Here we show that, despite their IL-10 production, CD46-induced T-regulatory T cells (Tregs) do not supp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2951

    authors: Barchet W,Price JD,Cella M,Colonna M,MacMillan SK,Cobb JP,Thompson PA,Murphy KM,Atkinson JP,Kemper C

    更新日期:2006-02-15 00:00:00

  • Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

    abstract::Rituximab therapy is associated with a long in vivo persistence, yet little is known about the effect of circulating rituximab on B-cell non-Hodgkin lymphoma (B-NHL) targeting by the other available anti-CD20 monoclonal antibodies (MoAbs) (131)iodine-tositumomab and (90)yttrium-ibritumomab tiuxetan. Therefore we asses...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-132142

    authors: Gopal AK,Press OW,Wilbur SM,Maloney DG,Pagel JM

    更新日期:2008-08-01 00:00:00